Rapid Urine Test Detects Bacteria Causing Pneumonia
By LabMedica International staff writers Posted on 28 Sep 2014 |
A simple, quick, first-of-a-kind urine test for detecting Streptococcus pneumoniae, one of the bacteria that are a leading cause of pneumonia, can also be used with cerebral spinal fluid (CSF) of patients with meningitis.
The aim of the test is to rule in S. pneumoniae as the probable cause of the pneumonia and the test results can enable a probable diagnosis to be made quicker so treatment can be started sooner with the appropriate antibiotics to combat the S. pneumoniae.
To do the test, a swab is dipped into a urine specimen, removed and inserted into a special test device. The test detects S. pneumoniae antigen in the urine of infected patients within 15 minutes. A positive result indicates that the patient most likely has pneumococcal pneumonia. Results should be confirmed with laboratory culture of the bacteria.
Conventional methods for diagnosing pneumonia, primarily using sputum or blood, are lengthy and require from two to three days up to several weeks. These conventional tests are often complex and the results are not always reliable. The new test, called Alere BinaxNOW Streptococcus pneumoniae Antigen Card (Binax, Inc.; Portland, ME, USA) is much quicker, more reliable and easier to use.
The Binax test was found to be 93% accurate in detecting S. pneumoniae when it was performed on urine samples from 373 patients known to have pneumococcal pneumonia. It was 78% accurate when performed on urine from 215 patients who had typical symptoms of pneumonia, but may not have had the disease. However, test results were not reliable in people who had been vaccinated for pneumonia within the past five days. The urine test’s sensitivity was 86% and specificity was 94%, while for CSF samples the sensitivity was 97% and specificity 99%.
It is often very difficult to distinguish between a respiratory infection that is caused by a virus and one which is caused by a bacterium and this is critical distinction because a viral infection will not respond to the commonly used antibiotics whereas a bacterial infection usually will. The Binax test can help in detecting the bacterium S. pneumoniae but it does not detect other bacteria nor does it detect viruses capable of causing pneumonia.
Related Links:
Binax, Inc.
The aim of the test is to rule in S. pneumoniae as the probable cause of the pneumonia and the test results can enable a probable diagnosis to be made quicker so treatment can be started sooner with the appropriate antibiotics to combat the S. pneumoniae.
To do the test, a swab is dipped into a urine specimen, removed and inserted into a special test device. The test detects S. pneumoniae antigen in the urine of infected patients within 15 minutes. A positive result indicates that the patient most likely has pneumococcal pneumonia. Results should be confirmed with laboratory culture of the bacteria.
Conventional methods for diagnosing pneumonia, primarily using sputum or blood, are lengthy and require from two to three days up to several weeks. These conventional tests are often complex and the results are not always reliable. The new test, called Alere BinaxNOW Streptococcus pneumoniae Antigen Card (Binax, Inc.; Portland, ME, USA) is much quicker, more reliable and easier to use.
The Binax test was found to be 93% accurate in detecting S. pneumoniae when it was performed on urine samples from 373 patients known to have pneumococcal pneumonia. It was 78% accurate when performed on urine from 215 patients who had typical symptoms of pneumonia, but may not have had the disease. However, test results were not reliable in people who had been vaccinated for pneumonia within the past five days. The urine test’s sensitivity was 86% and specificity was 94%, while for CSF samples the sensitivity was 97% and specificity 99%.
It is often very difficult to distinguish between a respiratory infection that is caused by a virus and one which is caused by a bacterium and this is critical distinction because a viral infection will not respond to the commonly used antibiotics whereas a bacterial infection usually will. The Binax test can help in detecting the bacterium S. pneumoniae but it does not detect other bacteria nor does it detect viruses capable of causing pneumonia.
Related Links:
Binax, Inc.
Read the full article by registering today, it's FREE!

Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
- Free digital version edition of LabMedica International sent by email on regular basis
- Free print version of LabMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of LabMedica International in digital format
- Free LabMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!

Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Microbiology News
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Genetic-Based Tool Predicts Survival Outcomes of Pancreatic Cancer Patients
A tumor marker is a substance found in the body that may signal the presence of cancer. These substances, which can include proteins, genes, molecules, or other biological compounds, are either produced... Read more
Urine Test Diagnoses Early-Stage Prostate Cancer
Prostate cancer is one of the leading causes of death among men worldwide. A major challenge in diagnosing the disease is the absence of reliable biomarkers that can detect early-stage tumors.... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreTechnology
view channel
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more